MSK K12 Clinical Translational Cancer Research Training Program

MSK K12 Clinical Translational Cancer Research Training Program

Share
Share

Paul Calabresi Career Development Award for Clinical Oncology

The Paul Calabresi Career Development Award for Clinical Oncology fosters a training program for clinical translational research at Memorial Sloan Kettering Cancer Center (MSK). The award provides three years of junior faculty funding to selected scholars.

Under the leadership of Simon Powell and Omar Abdel-Wahab, the award establishes a nationally recognized high-volume K12 program at MSK to train the next generation of translational cancer physicians.

This program seeks to recruit and train eligible MD, DO, and MD/PhD applicants derived from multiple specialties, including medical oncology, surgical oncology, GYN oncology, radiology, radiation oncology, pathology, neurology, pediatric oncology, and infectious diseases for careers in cancer related translational research.

Since the program was first funded in 2015, MSK has trained 26 K12 scholars. These scholars have published 123 papers (44 first-author), led clinical trials, and received peer-reviewed grant funding from federal agencies, professional societies, and foundations including the National Cancer Institute, American College of Nuclear Medicine, American Society of Clinical Oncology, Stand Up to Cancer, and Parker Institute for Cancer Immunotherapy.

In 2020, the grant was renewed for another five years, through 2025.

Learn more about the Paul Calabresi Career Development Award for Clinical Oncology: